0,912  0,005  Transcription factor NF kappa B inhibitor
0,893  0,002  Sensitization
0,862  0,008  Antiinflammatory
0,842  0,012  Apoptosis agonist
0,813  0,001  Abortion inducer
0,800  0,005  Chemopreventive
0,802  0,009  Teratogen
0,785  0,009  Embryotoxic
0,776  0,009  TNF expression inhibitor
0,755  0,008  Antihypercholesterolemic
0,731  0,016  Antineoplastic (breast cancer)
0,718  0,004  Antipyretic
0,717  0,016  Antineoplastic (lung cancer)
0,685  0,004  Antipruritic, allergic
0,687  0,014  Antileukemic
0,665  0,007  Nitric oxide antagonist
0,638  0,008  Antipsoriatic
0,637  0,010  Antineoplastic (melanoma)
0,642  0,014  Antibacterial
0,626  0,007  Antineoplastic (glioma)
0,613  0,016  Carcinogenic
0,608  0,012  Immunosuppressant
0,616  0,022  Antineoplastic (colorectal cancer)
0,608  0,021  Antineoplastic (colon cancer)
0,587  0,004  Non-steroidal antiinflammatory agent
0,588  0,015  Bone diseases treatment
0,578  0,012  Lipoprotein disorders treatment
0,580  0,017  Chemoprotective
0,565  0,015  Antineoplastic (pancreatic cancer)
0,541  0,006  Antiulcerative
0,556  0,023  Prostate cancer treatment
0,547  0,016  Hepatic disorders treatment
0,539  0,009  Antineoplastic (lymphoma)
0,537  0,010  Antineoplastic (glioblastoma multiforme)
0,522  0,005  Interferon gamma antagonist
0,522  0,005  Antiacne
0,518  0,004  UGT2B7 substrate
0,525  0,016  NOS2 expression inhibitor
0,519  0,011  Hypolipemic
0,513  0,007  Hair growth stimulant
0,513  0,019  Antifungal
0,509  0,019  Apoptosis antagonist
0,507  0,020  AR expression inhibitor
0,533  0,049  Caspase 9 stimulant
0,497  0,017  Antiprotozoal (Leishmania)
0,497  0,025  Cytotoxic
0,498  0,027  Antineoplastic (ovarian cancer)
0,487  0,019  Antineoplastic (multiple myeloma)
0,485  0,030  Respiratory analeptic
0,471  0,024  Antiosteoporotic
0,472  0,026  Cardioprotectant
0,445  0,005  Antipruritic, non-allergic
0,442  0,010  Hepatoprotectant
0,441  0,013  Transcription factor STAT3 inhibitor
0,449  0,037  Immunostimulant
0,432  0,021  Antiparasitic
0,426  0,019  Antineoplastic (renal cancer)
0,409  0,010  Prostate disorders treatment
0,442  0,043  Stroke treatment
0,437  0,041  Antithrombotic
0,407  0,015  Antihelmintic
0,410  0,019  Antineoplastic enhancer
0,414  0,027  Proliferative diseases treatment
0,403  0,020  Antineoplastic (endocrine cancer)
0,415  0,032  Antioxidant
0,387  0,013  Platelet adhesion inhibitor
0,409  0,037  ICAM1 expression inhibitor
0,407  0,038  Antineoplastic (brain cancer)
0,393  0,028  Tumour necrosis factor alpha release inhibitor
0,393  0,029  Hypoglycemic
0,393  0,031  Mutagenic
0,386  0,024  Antineoplastic (osteosarcoma)
0,429  0,076  Antidiabetic
0,429  0,076  Cyclophilin D inhibitor
0,364  0,011  Protein kinase stimulant
0,363  0,011  Protein-tyrosine phosphatase inhibitor
0,352  0,003  Ornithine decarboxylase inhibitor
0,366  0,019  Skin irritative effect
0,354  0,007  Protein-tyrosine phosphatase 1B inhibitor
0,374  0,028  Antineoplastic (liver cancer)
0,387  0,043  CYP2C19 substrate
0,368  0,028  Transcription factor STAT inhibitor
0,369  0,029  Sodium/bile acid cotransporter inhibitor
0,382  0,042  Analeptic
0,384  0,049  Caspase 3 stimulant
0,361  0,028  DNA synthesis inhibitor
0,345  0,017  Prostatic (benign) hyperplasia treatment
0,339  0,012  Antiviral (Influenza A)
0,364  0,040  Antineoplastic (non-small cell lung cancer)
0,351  0,028  Antihypertriglyceridemic
0,335  0,015  Gastrin inhibitor
0,339  0,021  Antiviral (Influenza)
0,316  0,003  Bile acid receptor antagonist
0,330  0,020  Contraceptive
0,316  0,010  Cholesterol synthesis inhibitor
0,347  0,042  Cytostatic
0,356  0,051  NOS3 expression inhibitor
0,338  0,036  Angiogenesis stimulant
0,306  0,009  Antifungal enhancer
0,365  0,073  CYP3A4 substrate
0,314  0,029  UGT1A1 substrate
0,324  0,049  Antihypoxic
0,280  0,006  Choleretic
0,315  0,043  Vascular (periferal) disease treatment
0,276  0,007  Contraceptive female
0,335  0,071  Cholesterol antagonist
0,292  0,037  UDP-glucuronosyltransferase substrate
0,305  0,051  Platelet antagonist
0,300  0,048  Acute neurologic disorders treatment
0,300  0,052  Cardiovascular analeptic
0,306  0,060  Antidiabetic (type 2)
0,252  0,008  Microtubule formation inhibitor
0,264  0,020  Phospholipase A2 inhibitor
0,250  0,011  Farnesoid X receptor antagonist
0,341  0,104  Histamine release inhibitor
0,302  0,069  Spasmolytic
0,240  0,008  Arachidonic acid antagonist
0,258  0,031  Lipocortins synthesis antagonist
0,233  0,006  Actinic keratosis treatment
0,231  0,007  ABCA1 expression enhancer
0,230  0,007  Transcription factor NF kappa B stimulant
0,327  0,104  Atherosclerosis treatment
0,284  0,062  Antineoplastic (cervical cancer)
0,252  0,031  Antiviral (Herpes)
0,218  0,008  TRPA1 agonist
0,222  0,013  Cyclooxygenase 3 inhibitor
0,248  0,042  P-glycoprotein inhibitor
0,213  0,015  Alcohol dehydrogenase substrate
0,204  0,006  CDC25A inhibitor
0,268  0,077  Renal disease treatment
0,192  0,005  5-Alpha-reductase inhibitor
0,189  0,006  Lipase inhibitor
0,228  0,053  Neurotrophic factor enhancer
0,174  0,003  Na+ K+ transporting ATPase inhibitor
0,210  0,039  Antineoplastic (squamous cell carcinoma)
0,178  0,010  Keratolytic
0,284  0,119  CYP2C9 substrate
0,190  0,025  Antihemorrhagic
0,205  0,040  Lipid peroxidase inhibitor
0,234  0,079  Vasodilator
0,165  0,010  Antiviral (SARS coronavirus)
0,165  0,010  Antiviral (Coronavirus)
0,164  0,011  Anabolic
0,158  0,005  Hypercalcemia treatment
0,290  0,138  15-Lipoxygenase inhibitor
0,183  0,032  Antiviral (Hepatitis B)
0,244  0,094  UGT2B4 substrate
0,161  0,011  Paget's disease treatment
0,151  0,003  Postcoital contraceptive
0,199  0,055  LDLR expression enhancer
0,176  0,035  Antihyperlipoproteinemic
0,143  0,004  Squalene synthetase inhibitor
0,227  0,089  Myocardial infarction treatment
0,156  0,018  Antibiotic
0,192  0,054  Eye irritation, high
0,179  0,042  Bone formation stimulant
0,235  0,101  Radioprotector
0,245  0,112  Antimycobacterial
0,160  0,029  Antineoplastic antibiotic
0,226  0,099  Antiprotozoal (Trypanosoma)
0,215  0,089  Antineoplastic (lymphocytic leukemia)
0,151  0,026  Antiinfertility, female
0,165  0,041  Adenylate cyclase stimulant
0,227  0,106  Antituberculosic
0,206  0,088  Cardiodepressant
0,174  0,056  Acute respiratory distress syndrome (ARDS) treatment
0,171  0,057  Antineoplastic (carcinoma)
0,205  0,094  Free radical scavenger
0,141  0,030  Beta glucuronidase inhibitor
0,177  0,070  UGT1A4 substrate
0,195  0,091  Antiparkinsonian, rigidity relieving
0,131  0,028  Androgen antagonist
0,145  0,044  Vanilloid 1 agonist
0,275  0,174  Antiarthritic
0,104  0,004  Retinoid X receptor agonist
0,104  0,005  Retinoid X alpha receptor agonist
0,148  0,050  DNA polymerase I inhibitor
0,149  0,055  Skin whitener
0,156  0,062  Antidiabetic (type 1)
0,101  0,008  Potassium channel Kv1.3 blocker
0,122  0,031  Antispirochetal
0,105  0,016  Anticholelithogenic
0,109  0,020  Potassium channel large-conductance Ca-activated activator
0,215  0,126  Lipoxygenase inhibitor
0,090  0,004  ATP citrate lysase inhibitor
0,194  0,108  RNA-directed DNA polymerase inhibitor
0,120  0,037  Antineoplastic alkaloid
0,141  0,065  Antieczematic
0,167  0,091  Antirickettsial
0,132  0,056  Growth stimulant
0,087  0,011  Heme oxygenase stimulant
0,098  0,023  Hyperparathyroidism treatment
0,237  0,163  Calcium channel activator
0,150  0,077  UGT2B9 substrate
0,077  0,005  Parathyroid hormone antagonist
0,152  0,081  UGT1A3 substrate
0,087  0,016  Nitric oxide donor
0,074  0,004  Retinoic acid receptor agonist
0,081  0,013  Lipocortins synthesis agonist
0,071  0,004  Retinoid X gamma receptor agonist
0,084  0,024  CDC25B inhibitor
0,132  0,072  Anesthetic
0,063  0,004  Vitamin D receptor antagonist
0,189  0,131  Interleukin agonist
0,177  0,119  VCAM1 expression inhibitor
0,111  0,057  HDL-cholesterol increasing
0,063  0,009  Farnesoid X receptor agonist
0,136  0,083  Corneal wound healing stimulator
0,056  0,005  Retinoid X beta receptor agonist
0,091  0,045  Vanilloid agonist
0,080  0,038  Glycine receptor agonist
0,052  0,011  Retinoid X receptor antagonist
0,232  0,192  CYP2C19 inhibitor
0,057  0,018  Microtubule stabilization
0,051  0,011  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,041  0,004  Progesterone receptor B antagonist
0,051  0,014  Retinoic acid alpha receptor agonist
0,041  0,004  Retinoid X gamma receptor antagonist
0,046  0,009  Retinoid X alpha receptor antagonist
0,166  0,130  Antiviral (HIV)
0,137  0,102  Melanin inhibitor
0,198  0,167  Immunomodulator
0,139  0,108  Dual specificity phosphatase inhibitor
0,034  0,004  Retinoid X beta receptor antagonist
0,040  0,011  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,060  0,031  Acetyl-CoA transferase 2 inhibitor
0,033  0,005  Retinoic acid gamma receptor agonist
0,031  0,004  Vitamin D receptor agonist
0,136  0,109  Dual specificity phosphatase 3 inhibitor
0,078  0,051  Narcotic antagonist
0,091  0,065  Antiviral (Rhinovirus)
0,169  0,144  Antidiabetic symptomatic
0,105  0,081  Proteasome inhibitor
0,038  0,017  RNA-directed RNA polymerase stimulant
0,028  0,006  Retinoic acid beta receptor agonist
0,081  0,060  Antiprotozoal activity enhancer
0,123  0,102  Diuretic
0,027  0,007  Retinoic acid receptor antagonist
0,141  0,120  UGT2B10 substrate
0,046  0,027  Liver X receptor agonist
0,054  0,036  Protein 50S ribosomal subunit inhibitor
0,027  0,008  Retinoic acid alpha receptor antagonist
0,059  0,042  Androgen agonist
0,026  0,009  Corticosteroid-like
0,144  0,126  Antineoplastic (bone cancer)
0,090  0,076  UGT2B11 substrate
0,092  0,079  Expectorant
0,035  0,023  HMG CoA reductase inhibitor
0,148  0,136  Insulin sensitizer
0,039  0,028  GABA uptake inhibitor
0,024  0,014  CYP24 inhibitor
0,054  0,045  Aromatase inhibitor
0,028  0,023  Liver X receptor alpha antagonist
0,039  0,036  Cholesterol absorption inhibitor
0,011  0,009  Retinoic acid receptor gamma antagonist
0,097  0,095  Photosensitizer
0,011  0,010  Retinoic acid beta receptor antagonist
0,027  0,026  Prostaglandin D2 agonist
0,004  0,003  Vitamin D-like
0,100  0,099  Estrogen antagonist

